Supernus Pharmaceuticals, Inc. (SUPN): Nilai pasar

Logo perusahaan publik Supernus (SUPN)

The market valuation visualization for Supernus Pharmaceuticals (SUPN) shows a capitalization of 2.44. Business stability in the US is guaranteed by patent protection and an absence of political risks. Supernus Pharmaceuticals (SUPN) focuses on ethical R&D to combat psychiatric disorders, attracting leading neurobiologists. Primary revenue is generated through the supply of specialized drugs to insurance funds for the therapy of ADHD and epilepsy.

SUPN Supernus: Kapitalisasi pasar ing interval 04.07.2022 - 23.10.2026

SUPN (Supernus Corp): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Supernus Pharmaceuticals (SUPN):
Kutipan saham Supernus|SUPN - Prakiraan konsensus analis|Nilai pasar Supernus Corp
Analisis fundamental perusahaan:SUPN (Supernus)
Sampel barang supernus.com

Patent protection for CNS drugs provides Supernus Pharmaceuticals (SUPN) with significant pricing power, directly impacting the investment attractiveness of its assets. Analyzing the company's current market capitalization, an investor assesses the aggregate value of all shares as an indicator of the business's market scale, where breaking through price levels signals either an expansion of fundamental value or an increase in the risk of capital loss.

Pesaing wigati

Biogen - Biji pasar|Kapitalisasi pasar Neurocrine NBIX|RGC - Nilai pasar|Biji pasar AXSM|ACADIA Pharmaceuticals (ACAD) - Nilai pasar|Kapitalisasi pasar XENE|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar CPRX (Catalyst Pharma)|Kapitalisasi pasar DNLI|HRMY - Nilai pasar|Biohaven Ltd. - Biji pasar|Kapitalisasi pasar amylyx.com AMLX|TRVI - Nilai pasar|Nilai pasar PRAX (Praxis Precision Medicines Inc)|Anavex Corp (AVXL) - Nilai pasar|Nilai pasar CeriBell EEG (CBLL)|Nilai pasar Prothena Corporation PLC|Alector Therapeutics (ALEC) - Kapitalisasi pasar|Biji pasar ANNX (Annexon)|Kapitalisasi pasar omeros.com (OMER)|Nilai pasar Neurogene Corp NGNE|ACIU (AC Immune Inc) - Biji pasar|Voyager Therapeutics - Kapitalisasi pasar|Nilai pasar neumoratx.com|Scilex (SCLX) - Nilai pasar|Tevogen Bio Holdings Inc. - Nilai pasar|Nilai pasar Alpha Cognition Inc|Kapitalisasi pasar CGTX (cogrx.com)|Biji pasar IKT (Inhibikase Therapeutics)|Kapitalisasi pasar cassavasciences.com (SAVA)|Nilai pasar Assertio ASRT|Kapitalisasi pasar Coya Therapeutics Inc (COYA)|VTGN: Biji pasar|Nilai pasar OVID (Ovid Therapeutics Inc.)|Acumen Pharmaceuticals (ABOS) - Nilai pasar|Biji pasar CRVO (cervomed.com)|ATHE (Alterity Therapeutics Ltd.) - Kapitalisasi pasar|CLNN: Nilai pasar|Kapitalisasi pasar PEPG|Kapitalisasi pasar jupiterneurosciences.com (JUNS)|Nilai pasar Relmada Therapeutics RLMD|Nilai pasar ANVS|GRCE - Nilai pasar|Firefly Neuroscience, Inc. (AIFF) - Biji pasar|KLTO: Kapitalisasi pasar|NeuroSense Therapeutics Ltd. (NRSN) - Kapitalisasi pasar|RVPH (Reviva Pharmaceuticals) - Kapitalisasi pasar|Biji pasar MetaVia, Inc. (MTVA)|Kapitalisasi pasar NRXS|HSDT - Nilai pasar|Passage Bio - Biji pasar|Kapitalisasi pasar Neuphoria Therapeutics, Inc. NEUP|NERV: Biji pasar|athira.com - Nilai pasar|ADXN: Kapitalisasi pasar|ALZN - Kapitalisasi pasar|CYCN (Cyclerion Therapeutics Inc.) - Kapitalisasi pasar|Biji pasar Protagenic (PTIX)|Kapitalisasi pasar KTTA|Kapitalisasi pasar cortigent.com (CRGT)|Nilai pasar Avenue Therapeutics, Inc. ATXI|Brainstorm Cell Therapeutics Inc. - Nilai pasar|CARA - Nilai pasar|Kapitalisasi pasar Chromocell CHRO|eliemtx.com (ELYM) - Nilai pasar|ITCI - Kapitalisasi pasar|Biji pasar LBPH|Kapitalisasi pasar Marinus Pharmaceuticals Inc|Nilai pasar NKGen (NKGN)|NRBO: Biji pasar|Nilai pasar Sage Therapeutics, Inc. SAGE|SNPX: Kapitalisasi pasar|TRVN - Nilai pasar|VIGL (Vigil Neuroscience) - Kapitalisasi pasar|WENA: Kapitalisasi pasar|Nilai pasar Cerevel Corp (CERE)